Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
bearish
Yunkang Group
Watchlist
Yunkang Group IPO - Futile to Try and Gauge Its Post-COVID Performance
Equity Capital Markets
2k Views
08 May 2022 01:52
Yunkang Group (2325 HK) is looking to raise US$139m in its Hong Kong IPO. Were China to lift its lockdown status, inline with global trends, the earnings profile for Yunkang would drastically alter.
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Event-Driven
Equity Bottom-Up
Index Rebalance
Japan
South Korea
India
Philippines
Equity Derivatives
Asia ECM
China
Trending Insights
More »
Nikkei 225 Proposal for Dealing With Sony's (6758) Sony Finl Spinoff - A Non-Event but TOPIX Isn't
Index Treatment of Sony (6758 JP)'s Spinoff of the Financial Services Business
UK: Some Workshy Start Looking
No, Hong Kong Won't Abandon The Peg
[Japan M&A] Carlyle Deal for TRYT (9164) - Great Exit for Speculators as HR Co Targets Are Desirable
Top Unpaywalled Insights
More »
Bearishness Persist in Soybeans Despite Rebound Hopes
Curator's Cut: The Next Labubu, Crypto Equities and Tracking APAC Buybacks
[IO Technicals 2025/23] Bearish Momentum Persists
VEON US: Pakistan Towers Sale Frees Capital for Digital Growth in Core Market Ahead of Ukraine IPO
Advanced Look: Navigating the New Macro Landscape Through Quantitative Alpha Generation Strategies
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Yungkang Group Lock-Up - Shares Benefited from a Protracted Lockdown. Shareholders Could Monetise
15 Nov 2022
ECM Weekly (22nd May 22) - JD, LIC, Delhivery, Leapmotor, Vista, Paradeep, Woori, Hyundai Heavy, NIO
21 May 2022
Yunkang Group IPO Trading - Subdued Subscription Rates Combined with Uncertain Future Profitability
17 May 2022
Yunkang Group IPO - Has Improved Its Operating Metrics, but Still Reliant on COVID Boost
05 May 2022
Yunkang Group Pre-IPO - Would Need to Prove Itself Post-COVID
24 Feb 2022
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x